AS 2 – Dementia and cognitive impairment2018-08-14T19:02:48+00:00

Dementia and cognitive impairment

Wednesday, 10.10.2018 | 08:00 – 09:45 am

08:00 –
08:15 am
Lianne Trigiani
(Montréal, Canada)
Benefits of voluntary aerobic physical exercise on cognition and white matter pathology in a mouse model of vascular cognitive impairment and dementia
08:15 –
08:30 am
Jessika Royea
(Montréal, Canada)
Angiotensin II type 2 receptors failed to rescue cognitive decline but had selective cerebrovascular benefits in a mouse model of Alzheimer’s disease
08:30 –
08:45 am
Maria Angeles Moro
(Madrid, Spain)
Searching for targets in post-stroke cognitive impairment: aberrant hippocampal neurogenesis
08:45 –
09:00 am
Gabrielle Mangin
(Paris, France)
Glatiramer Acetate reduces infarct volume in diabetic mice with cerebral ischemia and prevents long term memory loss
09:00 –
09:15 am
Gregory Bix
(Lexington , USA)
Cerebrovascular Changes in a Comorbidity Model of Vascular Dementia
09:15 –
09:30 am
Violeta Medina Alonso
(Madrid, Spain)
Spatial memory deficits are concomitant to an impaired hippocampal neurogenesis in a mouse model of cerebral hypoperfusion
09:30 –
09:45 am
Christof Haffner
(Munich, Germany)
CADASIL brain vessels show a HTRA1 loss-of-function profile